Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Biometrix Technology is a South Korea-based healthcare diagnostics company focused on molecular diagnostics and biochip-based DNA testing products. The company appears to commercialize in vitro diagnostic products for cardiac health and early cancer detection, with particular emphasis on HPV genotyping and other nucleic-acid-based diagnostic assays. Third-party company databases also indicate it has pursued additional therapeutic or research-stage assets, including ASI-001 and ASI-002, although public details on those programs are limited. Overall, the business looks primarily oriented toward diagnostic kits and related biochip technologies rather than a broad therapeutics pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Biometrix Technology.